Hemispherx BioPharma Inc. (Public, AMEX:HEB) At approximately 4:30pm EST, 5/15/09, StocksHaven Investments began the call conference scheduled with Chairman & CEO of Hemispherx BioPharma Inc., Dr. William Carter. The interview process was a tremendous success and was concluded as of 5:00pm EST, 5/15/09. Many issues and concerns of private individual investors were raised and answered [...]



